Keele Research Repository

Article

Schmid, P, Zaiss, M, Harper-Wynne, C, Ferreira, M, Dubey, S, Chan, S, Makris, A, Nemsadze, G, Brunt, AM, Kuemmel, S, Ruiz, I, Perelló, A, Kendall, A, Brown, J, Kristeleit, H, Conibear, J, Saura, C, Grenier, J, Máhr, K, Schenker, M, Sohn, J, Lee, KS, Shepherd, CJ, Oelmann, E, Sarker, S-J, Prendergast, A, Marosics, P, Moosa, A, Lawrence, C, Coetzee, C, Mousa, K and Cortés, J (2019) Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer. JAMA Oncology, 5 (11). 1556 - 1556.

Griffin, DR, Dickenson, EJ, Wall, PDH, Achana, F, Donovan, JL, Griffin, J, Hobson, R, Hutchinson, CE, Jepson, M, Parsons, NR, Petrou, S, Realpe, A, Smith, J, Foster, NE ORCID: https://orcid.org/0000-0003-4429-9756, Stevens, S, Gemperle-Mannion, E, Brown, J, Philippon, M, Beck, M, Donnell, JO, Robinson, D, Hughes, I, Hunter, D, Bennell, K, Bache, CE, McBryde, C, Politis, A, Bankes, M, George, M, Bartlett, G, Norton, M, Board, T, Mohammed, A, Rajpura, A, Cronin, M, Dandachli, W, Witt, J, Eastaugh-Waring, S, Fehily, M, Fern, D, Field, R, Stafford, G, Hashemi-Nejad, A, Khan, T, Kavathapu, V, Kiely, N, Whitaker, JP, Latimer, P, Madan, S, Malviya, A, Patil, S, Ramachandran, M, Sturridge, S, Thomas, P, White, C, Wilson, M, Williams, M, Jones, E, Baker, S, Stanton, J, Nicholls, C, Smeatham, A, Gosling, L, MacFarlane, K, Pressdee, F, Dickinson, G, Boulton, K, Goss, J, Venter, R, Kassam, J, Simmons, R, Poll, K, Bergmann, T, Pilkington, M, Armstrong, J, Wright, D, Dolphin, P, Bainbridge, K, Callum, M, Lewis, A, Smith, E, Cornes, V, Benfield, J, Monnington, K, Stewart, E, Borrill, S, Pinches, M, Dawson, S, Harding, N, Willis, M, Moore, D, MacCauley, A, Cooke, D, Fleck, R, Ball, J, Morrison, P, Kennedy, M, Turner, S, Bryant, C, Harris, K, McKeown, R, Clarkson, L, Lewis, A, Rowland-Axe, R, Grice, A, Githens-Mazer, G, Aughwan, H, Moore, F, Keeling, E, Amero, J, Atkinson, S, Graves, L, Fouracres, A, Hammonds, F, Curtis, J, Brackenridge, L, Taylor, T, Dobb, C, Whitworth, J, Commey, T, Limbani, V, Maclintock, H, Milne, A, Cleary, C, Murray, H, Dubia, M, Gokturk, A and Bray, R (2018) Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): a multicentre randomised controlled trial. The Lancet, 391 (10136). 2225 -2235.

Holden, MA, Burke, DL ORCID: https://orcid.org/0000-0003-2803-1151, Runhaar, J, van der Windt, DA, Riley, RD ORCID: https://orcid.org/0000-0001-8699-0735, Dziedzic, KS, Legha, A, Evans, AL, Abbott, JH, Baker, K, Brown, J, Bennell, KL, Bossen, D, Brosseau, L, Chaipinyo, K, Christensen, R, Cochrane, T, de Rooij, M, Doherty, M, French, HP, Hickson, S, Hinman, RS, Hopman-Rock, M, Hurley, MV, Ingram, C, Knoop, J, Krauss, I, McCarthy, C, Messier, SP, Patrick, DL, Sahin, N, Talbot, LA, Taylor, R, Teirlinck, CH, van Middelkoop, M, Walker, C, Foster, NE ORCID: https://orcid.org/0000-0003-4429-9756 and OA Trial Bank, . (2017) Subgrouping and TargetEd Exercise pRogrammes for knee and hip OsteoArthritis (STEER OA): a systematic review update and individual participant data meta-analysis protocol. BMJ Open, 7 (12). e018971 - ?.

Conference or Workshop Item

Holden, MA ORCID: https://orcid.org/0000-0003-0374-2862, Hattle, M, Runhaar, J, Riley, RD ORCID: https://orcid.org/0000-0001-8699-0735, Healey, EL ORCID: https://orcid.org/0000-0002-8356-0825, Quicke, JG ORCID: https://orcid.org/0000-0003-2418-2104, van der Windt, DA ORCID: https://orcid.org/0000-0002-7248-6703, Dziedzic, KS ORCID: https://orcid.org/0000-0002-1168-8993, van Middelkoop, M, Burke, D, Brown, J, Ingram, C, Taylor, R, Walker, C, Corp, N ORCID: https://orcid.org/0000-0002-6758-9513, Legha, A, Bierma-Zeinstra, S and Foster, NE (2022) MODERATORS OF THE EFFECT OF THERAPEUTIC EXERCISE FOR PEOPLE WITH KNEE AND/OR HIP OSTEOARTHRITIS: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS. In: 2022 OARSI World Congress on Osteoarthritis, 07-10 Apr 2022.

Schmid, P, Zaiss, M, Harper-Wynne, C, Ferreira, M, Dubey, S, Chan, S, Makris, A, Nemsadze, G, Brunt, AM, Kuemmel, S, Cabrero, IR, Perello, A, Kendall, A, Brown, J, Kristeleit, H, Conibear, J, Saura, C, Grenier, J, Mahr, K, Schenker, M, Sohn, JH, Lee, KS, Sarker, S-J, Coetzee, C, Mousa, K and Castan, JC (2018) MANTA - A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer. In: 2017 San Antonio Breast Cancer Symposium, December 5-9 2017, San Antonio, Texas.